| 000 | 02354cam a22003013u 4500 | ||
|---|---|---|---|
| 001 | 47767 | ||
| 003 | UtSlPG | ||
| 005 | 20260610134110.0 | ||
| 006 | m | ||
| 007 | cr n | ||
| 008 | 260607r2014||||utu|||||o|||||||||||||| d | ||
| 040 | _aUtSlPG | ||
| 041 | 7 |
_aen _2iso639-1 |
|
| 050 | 4 | _aRM | |
| 100 | 1 |
_aCouncil on Pharmacy and Chemistry _q(American Medical Association) |
|
| 245 | 1 | 4 | _aThe Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2 |
| 264 | 1 |
_aSalt Lake City, UT : _bProject Gutenberg, _c2014 |
|
| 300 |
_a1 online resource : _bmultiple file formats |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aRelease date is 2014-12-24 | ||
| 508 | _aProduced by David Edwards, Thiers Halliwell and the Online Distributed Proofreading Team at http://www.pgdp.net (This file was produced from images generously made available by The Internet Archive) | ||
| 520 | _a"The Propaganda for Reform in Proprietary Medicines, Vol. 2 of 2" is a scientific publication likely written in the early 20th century. This volume serves as a continuation of the efforts of the American Medical Association and the Council on Pharmacy and Chemistry to address issues related to proprietary medicines, focusing on reports and insights that emerged from 1917 to 1922. The text critically analyzes the evolution of proprietary medicine practices, particularly the dubious therapeutic claims associated with various products, many of which were exposed as ineffectual or fraudulent. At the start of this volume, the preface outlines the significant developments since the first volume, showcasing the Council's mission to protect both physicians and the public from misleading advertisements and claims surrounding proprietary medicines. It details the structure of the contents, including reports that assess medicinal products and the guidelines they must meet to be approved. This initial section emphasizes the importance of transparent information regarding composition and therapeutic claims, highlighting the Council's ongoing commitment to reform within the pharmaceutical industry. (This is an automatically generated summary.) | ||
| 534 | _nOriginal publication data not identified | ||
| 653 | _aPatent medicines | ||
| 856 | 4 | 0 | _uhttps://www.gutenberg.org/ebooks/47767 |
| 999 |
_c88606 _d88606 |
||